{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T03:53:55Z","timestamp":1649044435795},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00347-014-3201-2","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T20:06:30Z","timestamp":1417464390000},"page":"1219-1234","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapie der intermedi\u00e4ren Uveitis"],"prefix":"10.1007","volume":"111","author":[{"given":"D.","family":"Doycheva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zierhut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,3]]},"reference":[{"key":"3201_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"3201_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/09273940903348835","volume":"18","author":"Khairallah","year":"2010","unstructured":"Khairallah M (2010) Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN Working Group classification. Ocul Immunol Inflamm 18:2\u20134","journal-title":"Ocul Immunol Inflamm"},{"key":"3201_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","volume":"36","author":"Jakob","year":"2009","unstructured":"Jakob E, Reuland MS, Mackensen F et al (2009) Uveitis subtypes in a German interdisciplinary uveitis center \u2013 analysis of 1916 patients. J Rheumatol 36:127\u2013136","journal-title":"J Rheumatol"},{"key":"3201_CR4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3949\/ccjm.60.6.460","volume":"60","author":"Boskovich","year":"1993","unstructured":"Boskovich SA, Lowder CY, Meisler DM et al (1993) Systemic diseases associated with intermediate uveitis. Cleve Clin J Med 60:460\u2013465","journal-title":"Cleve Clin J Med"},{"key":"3201_CR5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bjophthalmol-2013-304589","volume":"98","author":"Heinz","year":"2014","unstructured":"Heinz C, Schoonbrood S, Heiligenhaus A (2014) Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome. Br J Ophthalmol 98:1107\u20131111","journal-title":"Br J Ophthalmol"},{"key":"3201_CR6","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ophtha.2006.03.027","volume":"113","author":"Lardenoye","year":"2006","unstructured":"Lardenoye CW, Kooij B van, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113:1446\u20131449","journal-title":"Ophthalmology"},{"key":"3201_CR7","unstructured":"Leitlinie Nr. 24a \u201eUveitis intermedia\u201c des Berufsverbandes der Augen\u00e4rzte Deutschlands und der Deutschen Ophthalmologischen Gesellschaft. Stand: Juli 2014"},{"key":"3201_CR8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC et al (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92:467\u2013471","journal-title":"Ophthalmology"},{"key":"3201_CR9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ajo.2011.02.009","volume":"152","author":"Leder","year":"2011","unstructured":"Leder HA, Jabs DA, Galor A et al (2011) Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol 152:441\u2013448","journal-title":"Am J Ophthalmol"},{"key":"3201_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73759-6","volume":"120","author":"Helm","year":"1995","unstructured":"Helm CJ, Holland GN (1995) The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 120:55\u201364","journal-title":"Am J Ophthalmol"},{"key":"3201_CR11","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2005.06.009","volume":"112","author":"Kok","year":"2005","unstructured":"Kok H, Lau C, Maycock N et al (2005) Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 112:1916\u20131921","journal-title":"Ophthalmology"},{"key":"3201_CR12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/112067210801800318","volume":"18","author":"Hogewind","year":"2008","unstructured":"Hogewind BF, Zijlstra C, Klevering BJ et al (2008) Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis. Eur J Ophthalmol 18:429\u2013434","journal-title":"Eur J Ophthalmol"},{"key":"3201_CR13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2008-1027762","volume":"226","author":"Roesel","year":"2009","unstructured":"Roesel M, Gutfleisch M, Heinz C et al (2009) Einfluss von intravitrealem und parabulb\u00e4rem Triamcinolon Acetonid auf die intraokulare Entz\u00fcndung bei aktiver nicht-infekti\u00f6ser Uveitis. Klin Monatsbl Augenheilkd 226:110\u2013114","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3201_CR14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/IAE.0b013e3181e378af","volume":"31","author":"Bae","year":"2011","unstructured":"Bae JH, Lee CS, Lee SC (2011) Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Retina 31:111\u2013118","journal-title":"Retina"},{"key":"3201_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09273940500545684","volume":"14","author":"Kooij","year":"2006","unstructured":"Kooij B van, Rothova A, Vries P de (2006) The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. Ocul Immunol Inflamm 14:73\u201385","journal-title":"Ocul Immunol Inflamm"},{"key":"3201_CR16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","volume":"129","author":"Lowder","year":"2011","unstructured":"Lowder C, Belfort R Jr, Lightman S et al (2011) Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129:545\u2013553","journal-title":"Arch Ophthalmol"},{"key":"3201_CR17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.126.9.1191","volume":"126","author":"Callanan","year":"2008","unstructured":"Callanan DG, Jaffe GJ, Martin DF et al (2008) Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol 126:1191\u20131201","journal-title":"Arch Ophthalmol"},{"key":"3201_CR18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00417-006-0512-2","volume":"245","author":"Ziemssen","year":"2007","unstructured":"Ziemssen F, Deuter CM, Stuebiger N et al (2007) Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol 245:917\u2013918","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3201_CR19","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.ophtha.2006.11.028","volume":"114","author":"Cordero-Coma","year":"2007","unstructured":"Cordero-Coma M, Sobrin L, Onal S et al (2007) Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology 114:1574\u20131579","journal-title":"Ophthalmology"},{"key":"3201_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/IAE.0b013e318156db75","volume":"28","author":"Mackensen","year":"2008","unstructured":"Mackensen F, Heinz C, Becker MD et al (2008) Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study. Retina 28:41\u201345","journal-title":"Retina"},{"key":"3201_CR21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ajo.2009.03.028","volume":"148","author":"Acharya","year":"2009","unstructured":"Acharya NR, Hong KC, Lee SM (2009) Ranibizumab for refractory uveitis-related macular edema. Am J Ophthalmol 148:303\u2013309","journal-title":"Am J Ophthalmol"},{"key":"3201_CR22","unstructured":"Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augen\u00e4rzte Deutschlands zur intravitrealen Therapie des Makula\u00f6dems bei Uveitis. Stand: 02.07.2014"},{"key":"3201_CR23","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/IAE.0b013e31828ac07d","volume":"33","author":"Taylor","year":"2013","unstructured":"Taylor SR, Banker A, Schlaen A et al (2013) Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis. Retina 33:2149\u20132154","journal-title":"Retina"},{"key":"3201_CR24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/IAE.0b013e3181d3758a","volume":"30","author":"Farvardin","year":"2010","unstructured":"Farvardin M, Afarid M, Mehryar M et al (2010) Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis. Retina 30:1530\u20131535","journal-title":"Retina"},{"key":"3201_CR25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/jop.2011.0199","volume":"28","author":"Farvardin","year":"2012","unstructured":"Farvardin M, Afarid M, Shahrzad S (2012) Long-term effects of intravitreal infliximab for treatment of sight-threatening chronic noninfectious uveitis. J Ocul Pharmacol Ther 28:628\u2013631","journal-title":"J Ocul Pharmacol Ther"},{"key":"3201_CR26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/IAE.0b013e3181bcef3b","volume":"30","author":"Giganti","year":"2010","unstructured":"Giganti M, Beer PM, Lemanski N et al (2010) Adverse events after intravitreal infliximab (Remicade). Retina 30:71\u201380","journal-title":"Retina"},{"key":"3201_CR27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2012.05.011","volume":"154","author":"Yeh","year":"2012","unstructured":"Yeh S, Albini TA, Moshfeghi AA et al (2012) Uveitis, the Comparision of Age-Related Macular Treatments Trials (CATT), and intravitreal biologics for ocular inflammation. Am J Ophthalmol 154:429\u2013435","journal-title":"Am J Ophthalmol"},{"key":"3201_CR28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492\u2013513","journal-title":"Am J Ophthalmol"},{"key":"3201_CR29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3129\/i10-081","volume":"45","author":"Cunningham","year":"2010","unstructured":"Cunningham ET Jr, Wender JD (2010) Practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol 45:352\u2013358","journal-title":"Can J Ophthalmol"},{"key":"3201_CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1002469503835","volume":"97","author":"Zierhut","year":"1999","unstructured":"Zierhut M, Thiel HJ, Schlote T (1999) Treatment of uveitic macular edema with acetazolamide. Doc Ophthalmol 97:409\u2013413","journal-title":"Doc Ophthalmol"},{"key":"3201_CR31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00006982-200502000-00011","volume":"25","author":"Schilling","year":"2005","unstructured":"Schilling H, Heiligenhaus A, Laube T et al (2005) Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation. Retina 25:182\u2013188","journal-title":"Retina"},{"key":"3201_CR32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","volume":"112","author":"Nussenblatt","year":"1991","unstructured":"Nussenblatt RB, Palestine AG, Chan CC (1991) Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 112:138\u2013146","journal-title":"Am J Ophthalmol"},{"key":"3201_CR33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00417-005-0066-8","volume":"244","author":"Siepmann","year":"2006","unstructured":"Siepmann K, Huber M, St\u00fcbiger N et al (2006) Mycophenolate mofetil is highly effective and safe immunosuppressive agent for the treatment of uveitis: a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol 244:788\u2013794","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3201_CR34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2008.03.004","volume":"146","author":"Teoh","year":"2008","unstructured":"Teoh SC, Hogan AC, Dick AD et al (2008) Mycophenolate mofetil for the treatment of uveitis. Am J Ophthalmol 146:752\u2013760","journal-title":"Am J Ophthalmol"},{"key":"3201_CR35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00417-011-1731-8","volume":"249","author":"Doycheva","year":"2011","unstructured":"Doycheva D, Zierhut M, Blumenstock G et al (2011) Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol 249:1235\u20131243","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3201_CR36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2008-1027134","volume":"225","author":"Pleyer","year":"2008","unstructured":"Pleyer U, Ruokonen P, Schmidt N et al (2008) Ein Beitrag zur Anwendung von Mycophenols\u00e4ure bei Autoimmunerkrankungen des Auges: K\u00f6nnen wir die Therapie optimieren? Klin Monatsbl Augenheilkd 225:66\u201369","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3201_CR37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/09273940903137675","volume":"17","author":"Deuter","year":"2009","unstructured":"Deuter CM, Doycheva D, Stuebiger N et al (2009) Mycophenolate sodium for immunosuppressive treatment in uveitis. Ocul Immunol Inflamm 17:415\u2013419","journal-title":"Ocul Immunol Inflamm"},{"key":"3201_CR38","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","volume":"116","author":"Gangaputra","year":"2009","unstructured":"Gangaputra S, Newcomb CW, Liesegang TL et al (2009) Methotrexate for ocular inflammatory diseases. Ophthalmology 116:2188\u20132198","journal-title":"Ophthalmology"},{"key":"3201_CR39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","volume":"148","author":"Pasadhika","year":"2009","unstructured":"Pasadhika S, Kempen JH, Newcomb CW et al (2009) Azathioprine for ocular inflammatory diseases. Am J Ophthalmol 148:500\u2013509","journal-title":"Am J Ophthalmol"},{"key":"3201_CR40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archopht.123.5.634","volume":"123","author":"Murphy","year":"2005","unstructured":"Murphy CC, Greiner K, Plskova J et al (2005) Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. Arch Ophthalmol 123:634\u2013641","journal-title":"Arch Ophthalmol"},{"key":"3201_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/09273948.2012.723107","volume":"21","author":"Cordero-Coma","year":"2013","unstructured":"Cordero-Coma M, Yilmaz T, Onal S (2013) Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis. Ocul Immunol Inflamm 21:19\u201327","journal-title":"Ocul Immunol Inflamm"},{"key":"3201_CR42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2147\/OPTH.S3308","volume":"3","author":"Mackensen","year":"2009","unstructured":"Mackensen F, Max R, Becker MD (2009) Interferons and their potential in the treatment of ocular inflammation. Clin Ophthalmol 3:559\u2013566","journal-title":"Clin Ophthalmol"},{"key":"3201_CR43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000336324","volume":"51","author":"Deuter","year":"2012","unstructured":"Deuter C, St\u00fcbiger N, Zierhut M (2012) Interferon-\u03b1 therapy in noninfectious uveitis. Dev Ophthalmol 51:90\u201397","journal-title":"Dev Ophthalmol"},{"key":"3201_CR44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0002-9394(03)00314-3","volume":"135","author":"Holland","year":"2003","unstructured":"Holland GN, Stiehm ER (2003) Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol 135:867\u2013878","journal-title":"Am J Ophthalmol"},{"key":"3201_CR45","first-page":"362","volume":"32","author":"Foeldvari","year":"2005","unstructured":"Foeldvari I, Wierk A (2005) Methotrexat is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 32:362\u2013365","journal-title":"J Rheumatol"},{"key":"3201_CR46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/112067210701700509","volume":"17","author":"Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Mingels A, Heinz C et al (2007) Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol 17:743\u2013748","journal-title":"Eur J Ophthalmol"},{"key":"3201_CR47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bjo.2006.094698","volume":"91","author":"Doycheva","year":"2007","unstructured":"Doycheva D, Deuter C, Stuebuger N et al (2007) Mycophenolate mofetil in the treatment of uveitis of children. Br J Ophthalmol 91:180\u2013184","journal-title":"Br J Ophthalmol"},{"key":"3201_CR48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/eye.2011.23","volume":"25","author":"Chang","year":"2011","unstructured":"Chang PY, Giuliari GP, Shaikh M et al (2011) Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye 25:427\u2013435","journal-title":"Eye"},{"key":"3201_CR49","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0161-6420(98)91120-4","volume":"105","author":"Walton","year":"1998","unstructured":"Walton RC, Nussenblatt RB, Whitcup SM (1998) Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents. Ophthalmology 105:2028\u20132034","journal-title":"Ophthalmology"},{"key":"3201_CR50","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.82.7.737","volume":"82","author":"Kilmartin","year":"1998","unstructured":"Kilmartin DJ, Forrester JV, Dick AD (1998) Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 82:737\u2013742","journal-title":"Br J Ophthalmol"},{"key":"3201_CR51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3928\/01913913-20070101-03","volume":"44","author":"Schatz","year":"2007","unstructured":"Schatz CS, Uzel JL, Leininger L et al (2007) Immunosuppressants used in a steroid-sparing strategy for childhood uveitis. J Pediatr Ophthalmol Strabismus 44:28\u201334","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"3201_CR52","first-page":"1146","volume":"34","author":"Foeldvari","year":"2007","unstructured":"Foeldvari I, Nielsen S, K\u00fcmmerle-Deschner J et al (2007) Tumor necrosis factor-\u03b1 blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 34:1146\u20131150","journal-title":"J Rheumatol"},{"key":"3201_CR53","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bjophthalmol-2013-303935","volume":"98","author":"Doycheva","year":"2014","unstructured":"Doycheva D, Zierhut M, Blummenstock G et al (2014) Immunomodulatory therapy with tumour necrosis factor \u03b1 inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol 98:523\u2013528","journal-title":"Br J Ophthalmol"},{"key":"3201_CR54","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ajo.2005.07.017","volume":"140","author":"Becker","year":"2005","unstructured":"Becker M, Davis J (2005) Vitrectomy in the treatment of uveitis. Am J Ophthalmol 140:1096\u20131105","journal-title":"Am J Ophthalmol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-014-3201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-014-3201-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-014-3201-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T11:40:04Z","timestamp":1598528404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-014-3201-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3201"],"URL":"https:\/\/doi.org\/10.1007\/s00347-014-3201-2","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}